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ABSTRACT: Biofilm colonies are typically resistant to
general antibiotic treatment and require targeted methods
for their removal. One of these methods includes the use of
nanoparticles as carriers for antibiotic delivery, where they
randomly circulate in fluid until they make contact with the
infected areas. However, the required proximity of the
particles to the biofilm results in only moderate efficacy. We
demonstrate here that the nonpathogenic magnetotactic
bacteria Magnetosopirrillum gryphiswalense (MSR-1) can be
integrated with drug-loaded mesoporous silica microtubes
to build controllable microswimmers (biohybrids) capable of antibiotic delivery to target an infectious biofilm. Applying
external magnetic guidance capability and swimming power of the MSR-1 cells, the biohybrids are directed to and
forcefully pushed into matured Escherichia coli (E. coli) biofilms. Release of the antibiotic, ciprofloxacin, is triggered by the
acidic microenvironment of the biofilm, ensuring an efficient drug delivery system. The results reveal the capabilities of a
nonpathogenic bacteria species to target and dismantle harmful biofilms, indicating biohybrid systems have great potential
for antibiofilm applications.
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Biofilms are composed of heterogeneous communities ofbacteria encased in a self-extruded polymeric matrixknown as exopolysaccharides (EPS), whose formation is
a survival mechanism that enables bacteria to adapt and protect
themselves from hostile environments, antibiotics, or the
immune systems of host organisms.1 Numerous research
methodologies have explored the formation of biofilms and
possibilities for their eradication. Biofilms are pervasive in
industrial settings, resulting in metallic corrosion or fluid
blockage,2 as well as hospital environments, where they can
develop on medical implants or wounds, causing devastating
infections.3 An added burden is the increased resistivity of
bacteria and biofilms to current antibiotics4 and their ability to
develop a tolerance to antibiotics after repeated exposure.5
Consequently, the economic and social impact of biofilms is
considerable, with infections being the fourth leading cause of
death in hospitals in the USA6 with significant financial costs to
target bacteria infections.7 One of the most common,
noninvasive methods for treating clinical bacterial infections is
the administration of broad spectrum antibiotics. In this
fashion, the nontargeted delivery mechanism is not always
successful at destroying biofilms, as biofilms are less susceptible
to antibiotics when compared to planktonic bacteria.8,9 Bacteria
antibiotic resistance can develop; thereupon stronger medi-
cation or surgical options are needed to remove the biofilm.
Other methods for reducing the risk of localized bacterial
infections include treating the surfaces of bacteria-prone areas
(e.g., medical implants, tooth surfaces) with antifouling
properties such as silver nanoparticles10 or antibiotic-loaded
nanoparticles,11 but these surface treatments can only target
biofilm at the material interface and over time can become inert
due to protein adhesion.12 Unbound liposomes13 and nano-
particles14 have also shown promise for drug delivery to treat
Received: June 13, 2017
Accepted: September 21, 2017





© 2017 American Chemical Society 9968 DOI: 10.1021/acsnano.7b04128
ACS Nano 2017, 11, 9968−9978
This is an open access article published under an ACS AuthorChoice License, which permits
copying and redistribution of the article or any adaptations for non-commercial purposes.
biofilms or cancer; however these targeted measures are limited
by their dependence on host circulation and serendipitous
encounters with biofilm interfaces, limiting their potency.
Micro- and nanoswimmers offer an alternative and capable
method for targeted drug delivery,15,16 and the fluidic
propulsion that bacteria create can be an optimal energy
source for biohybrid swimmers.17,18 Biohybrid swimmers merge
active motile cells with an artificial material, where the cells
simultaneously act as bioengines and biosensor (pH, temper-
ature, chemical) and the artificial cargo load can serve as the
drug delivery device.19 The artificial and cellular components of
the biohybrids form an active swimming system with greater
navigation and sensing capabilities than monocomponent
swimmers (either biological or artificial) or magnetic
particles.20−22 Recent biohybrid microsystem publications
have utilized sperm cells,23,24 contractive muscle cells,25−27
and bacteria28,29 to create micro- or macroscale actuators to
perform work for potential biomedical applications, but
implementing biohybrids for biofilm treatments has not yet
been explored. Here, we present magnetotactic bacteria
biohybrid microswimmers for antibiotic delivery to biofilms
that address problems with current antibiofilm agents. Earlier
biohybrid work using magnetotactic bacteria propulsion has
proven bacteria are capable of micromanipulation,30 microself-
assembly,31,32 and carrying cargo loads in microfluidic
devices.33 More recently, the magnetotactic bacteria Magneto-
coccus marinus (MC-1), were used to power biohybrids for in
vivo tumor targeting in mice, indicating magnetotactic bacteria
have potential for clinical applications after further immune
response studies.34 For the locomotive component or the
presented biohybrid, the magnetotactic bacteria Magneto-
sopirrillum gryphiswalense, MSR-1, were chosen to power the
swimmer due to their capacity to sense and respond to their
surrounding environment, ability to be externally guided with
low magnetic fields, and rapid and high-density culture cycle.35
MSR-1 bacteria swim using rotating bipolar flagella and contain
a chain of self-produced magnetosome nanoparticles composed
of Fe3O4 (Figure 1A) that assist in directing the cells to
preferred oxygen concentrations in their native aquatic
enviornments.36 MSR-1 cells were strategically adhered inside
mesoporous silica microtube (MSM) structures that had been
preloaded with the antibiotic ciprofloxacin (CFX). Mesoporous
silica is biocompatible and has a high surface area that is apt for
drug storage and delivery,37 and the tubular structure of the
chassis has been shown in our previous report to be a beneficial
configuration for improved bacteria biohybrid directional
swimming.38 The MRS-1-CFX-MSM biohybrid system was
capable of being magnetically guided to E. coli biofilms,
penetrating into the biofilm, and releasing the CFX cargo load,
triggered by the low pH of the biofilm microenvironment.
RESULTS
Formation and Characterization of Biohybrids. The
tubular, mesoporous silica chassis of the biohybrid was
fabricated using an organic synthesis method with a
commercially available polycarbonate (PC) membrane tem-
plate. Mesoporous silica formed within the 2 μm pores of the
template, and after polishing, mesoporous silica microtubes
were released by chemical solvation of the template and
subsequent washing and sonication (Figure 1B). The conical
pores of the membrane formed the asymmetric shape of the
MSMs, and the MSMs were produced in two lengths, long
Figure 1. Characterizing bacteria-driven biohybrid microswimmers. (A) SEM image of MSR-1 bacterium. Inset displays TEM of MSR-1 and
internal magnetosome chain. Inset Scale bar = 500 nm. (B) TEM image of pores in MSMs. Inset displays bright field microscopy images of
long and short MSMs. Inset scale bar = 10 μm. (C) SEM of MSR-1 cells captured within a microtube. Inset displays increased magnification of
bacteria in tube. Inset scale bar = 500 nm. (D) Bright field microscopy images of MSR-1-powered biohybrid swimming. Blue arrow indicates
location of MSR-1 inside the microtube. Red track indicates the trajectory of the biohybrid.
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(∼20 μm in length) and short (∼10 μm in length), where short
MSMs were due to breaking of single long MSMs. Trans-
mission electron microscopy (TEM) images of the MSMs show
nanoscale pores distributed throughout the tube body. After
characterization of the MSMs, biohybrids were created by
incubating MSR-1 with MSMs in a buffer solution for 15 min
with gentle shaking to promote MSR-1 encounters and
adhesion with the tubes. MSR-1 adhered inside the tube and
were capable of swimming with the tube over prolonged
durations. Scanning electron microscopy (SEM) images in
Figure 2. Magnetically guided swimming. (A) Track of a single biohybrid (left) guided with an external magnetic coil system (right). The
starting point of the track is indicated with a blue arrow. (B) Trajectories of free MSR-1 cells or biohybrids moving in a periodically reversing
magnetic field. Arrow indicates the general direction of swimming. (C) Sine of the angle (sin θ) of the cell or biohybrid in the rotating
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Figure 1C display MSR-1 partially penetrating MSMs. The
flagella of the MSR-1 with or without the tube could not be
observed, but it is hypothesized that the flagella motion of
MSR-1 is similar to Spirillum volutans bacteria, where the
rotating flagella cause the cell body to rotate in the opposite
direction, eliminating torque.39 Once the MSR-1 are within the
MSM, it is unknown if both flagella or only a single flagella are
rotating, but the biohybrids exhibit continuous directional
motion. Specific bacteria adhesion inside the tubes was
controlled by providing amine chemical moieties only inside
the MSM structure (Supporting Information, Figure S1).
Limited studies have examined the adhesion of magnetotactic
bacteria to surfaces, but the positive charge of the surface-
bound (3-aminopropyl)triethoxysilane (APTES) may promote
bacteria adhesion due to van der Waals and electrostatic
forces.12 APTES localized within the MSMs created guided cell
adhesion generating unidirectional forces from the bacteria
flagella and allowing the biohybrid to swim efficiently (Figure
1D). The choice of using a magnetically guidable bacteria
instead of a magnetically guidable microtube chassis was based
upon the multiple capabilities of the MSR-1: swimming,
sensing, and magnetic sensitivity. This permitted a larger variety
of materials for the tube chassis, materials such as mesoporous
silica, which is ideal for drug storage and delivery. As mentioned
in our previous article, addition of magnetic components to the
chassis increased the density of the microtube; bacteria were
still capable of attaching to the microtube, but most biohybrids
were not able to swim with the heavier load.38 Use of MSR-1
bacteria resolves this issue.
Once the biohybrid was formed, the microswimmer could be
magnetically guided using a permanent magnet (Video SV1) or
using electromagnetic coils as seen in Figure 2. The magnetic
field, B, induced a torque that passively aligned the MSR-1
along the magnetic field lines, forcing the bacteria to swim in a
single direction. Biohybrids were capable of following constant
changes in the magnetic field and could be directed to swim in
complex microtrajectories, such as a figure-eight (Figure 2A,
Video SV2), demonstrating they can operate in microenviron-
ments and be guided to biofilm locations. To further investigate
their swimming trajectories under magnetic fields, free
swimming MSR-1, short biohybrids, and long biohybrids
were observed swimming in a periodically reversing magnetic
field using the “U-turn method”.40 By reversing a 6 mT
magnetic field every 6 s, MSR-1 cells responded by changing
their swimming direction and completing a U-turn. The U-turn
method is often used to find the magnetic moment of
magnetotactic bacteria,41 but it can also be used to analyze
the performance of a magnetically guided biohybrid. Figure 2B
displays examples of trajectories of the cells and biohybrids in
the switching field. The velocities of the biohybrids, long (4 ± 1
μm/s) and short (8 ± 1 μm/s), are slower than the free
bacteria and cause the length and diameter of their U-turn
trajectories to be much shorter, with the longer biohybrids
having U-turns with the lowest diameters. The free-swimming
MSR-1 have a higher velocity (21 ± 5 μm/s), so they are
capable of swimming larger distances between each field
reversal and have a greater diameter in their U-turn trajectory
compared to the biohybrids. The sine of the angle (sin θ) of the
free bacteria or biohybrid relative to the x−y plane was also
measured over time (Figure 2C) and assisted in visualizing the
duration of the U-turns. The free bacteria responded almost
instantaneously to the reversal in magnetic field; however the
biohybrids needed greater time in reversing their direction
(Figure 2D). The delay in changing direction is attributed to
the increased force required for the MSR-1 to rotate the tube,
but they are still capable of rotating the MSM 180° within the 6
s window. Figure 2B and C provide useful insight on biohybrid
rotation capabilities and response time within the magnetic
field. The diminished U-turn diameters and the slower turning
times of the long biohybrids indicate that there is an upper limit
to the length of the MSM that is capable of being reoriented by
MSR-1 in a magnetic field. Although longer MSMs would be
capable of carrying larger drug doses, there would be a small
sacrifice in maneuverability. Shorter biohybrids would be more
Figure 3. pH-triggered release of CFX antibiotics from CFX-MSMs. (A) CFX release over time from CFX-MSMs at pH 5.8 and 7.4. Error bars
indicate the SD of the mean (n = 6). Inset displays MSR-1 swimming with a CFX-MSM. (Left) Bright field image of MSR-1 (blue arrow)
swimming with an MSM and (Right) fluorescence image of CFX loaded in the tube. Inset scale bar = 10 μm. (B) Confocal imaging of live cells
(green), dead cells (red), and localized acidic environments (blue) within an E. coli biofilm. (C) The x−z plane from (b) is separated into
individual fluorescence panels. Acidic microenvironments were labeled with the pH-sensitive dye, LysoSensor Blue (fluoresces only when pKa
< 5.2). (D) Compressed confocal stacks of CFX-MSMs biohybrids in an E. coli biofilm over 24 h. Observed fluorescence is due only to CFX.
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advantageous for guidance to microscale or mobile targets. This
information will be essential for future development of bacteria-
powered biohybrids and in vivo applications.
Coordinating biohybrid swimming is recognized as a
significant challenge in the field of biohybrids, as a significant
number of the biohybrids are needed to deliver therapeutic
doses of medicine. We acknowledge similar difficulties with the
presented microswimmer platform, as not every MSM captures
a bacterium. Currently we cannot separate biohybrids from free
swimming bacteria, making it difficult to quantitatively confirm
the yield of success to biohybrid form. However, there has been
success in collecting and monitoring the swimming behavior of
small groups of biohybrids. Using an external magnetic field,
clusters of biohybrids were observed swimming and operating
together. An example is shown in Figure 2E (Video SV3),
where four biohybrids swim in unison in the direction of the
magnetic field. Unified group swimming of large quantities of
biohybrids is recommendable for macroscale targets, such as
tumors,34 but small clusters of biohybrids have an advantage for
aiming at smaller targets, such as biofilms. Infectious biofilms
are mobile and heterogeneous with scale sizes in the
micrometer range. Instead of overwhelming the drug delivery
target with biohybrids to increase efficacy, biohybrids may also
operate in a “stealth” mode, where antibiotic can be delivered
to precise locations to do the most damage. Targeted delivery
of antibiotics and biofilm disruption is discussed further in later
results.
CFX and CFX-MSMs with Bacteria and Biofilms. The
fluoroquinolone antibiotic CFX was chosen to load the MSMs
for four major reasons: (1) CFX is a clinically relevant
antibiotic and is prescribed for numerous bacterial infections,
(2) the low dose of antibiotic needed for the minimum
inhibitory concentration (MIC) for E. coli,42 (3) the solubility
of CFX is dependent on solution pH, and (4) the fluorescence
of the antibiotic is in the visible spectrum, providing a facile
method for detection and concentration analysis. MSR-1 and E.
coli behavior and viability in the presence of CFX are discussed
in the Supporting Information (Figure S2). To load MSMs
with CFX, MSMs were incubated in an aqueous acidic CFX
solution overnight and then washed to produce CFX-MSMs.
The solubility of CFX in aqueous solutions is pH dependent,
only becoming soluble in acidic solutions, so the release of CFX
from CFX-MSMs was meaured at two different pH’s in motility
media, 5.8 and 7.4 (Figure 3A). At pH 7.4, almost no CFX was
released from the tubes over 24 h, but there was a significant
increase in release when the pH of the soltuion was lowered to
5.8. After 24 h, ∼0.04 μg mL−1 of CFX had been released from
105 MSMs, illustrating that pH could be used as a trigger to
release the antibiotic from the MSMs. As biofilms have
previously shown localized acidic microenviornments within
the biofilm,43,44 they are an ideal spark to initiate CFX release
from CFX-MSMs. In Figure 3B, an E. coli biofilm had live cells
(green), dead cells (red), and acidic microenviornments of cells
and EPS (blue) fluorescently labeled. Acidic regions were
labeled with a pH-sensitive probe, LysoSensor Blue DND-167,
which is essentially nonfluorescent when the pKa > 5.2. It is
observed in the black and white x−z cross sections of the
biofilm image (Figure 3C) that the LysoSensor dye stained a
significant portion of the interior of the biofilm, indicating a
localized acidic microenivornment which included live and dead
MSR-1. To ensure these observed acidic pockets in the biofilm
would trigger CFX relase from CFX-MSMs, CFX-MSMs were
incubated in 48 h E. coli biofilms and had their CFX
fluorescence monitored over time with confocal microscopy
(Figure 3D, Video SV4). After 6 h it is noted that surrounding
bacteria in the biofilm also become fluorescent as they absorb
the released CFX from the CFX-MSMs. At 24 h, a significant
portion of the surrounding biofilm and bacteria are fluorescent,
revealing the biofilms are suitable for triggering release of the
antibiotic from CFX-MSMs.
Figure 4. E. coli biofilm disruption. Overnight cultured biofilms had live (green) and dead cells (red) compared in 350 × 350 μm2 3D confocal
images. (A, B) Unmodified control biofilms, (C, D) biofilms with MSMs, and (E, F) biofilms with CFX-MSMs were compared at the time of
incubation with the microtubes (0 h) and 24 h later. CFX fluorescence is shown in e and f in cyan. (G) CV absorbance analysis of biofilms
after 24 or 48 h of incubation with biohybrids (CFX-MSMs+MSR-1) and control groups. Error bars indicate the SD of the mean (n = 15), and
statistical significance (with P < 0.01) is indicated with * for data sets that are significantly different between the 24 and 48 h time points.
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Biofilm Disruption with Biohybrids. E. coli biofilms were
cultured for 24 h on glass coverslips, washed with motility
media, and then left unmodified, incubated with MSMs, or
incubated with antibiotic-loaded CFX-MSMs for another 24 h.
Live/dead cell staining was performed at the moment of
microtube incubation (0 h) or 24 h after (Figure 4A−F). 3D
confocal imaging of the biofilms displays clusters of E. coli on
the surface. Unmodified biofilms displayed no visual change
over a 24 h period (Figure 4A,B), and biofilms incubated with
MSMs also had limited variations in bacteria density (Figure
4C,D), but biofilms incubated with CFX-MSMs had a
significant change in biofilm structure after 24 h (Figure
4E,D). CFX-MSMs biofilms exhibited a decrease in clustering
after incubation with the antibiotic tubes, and final bacteria
density was visibly lower compared to the 0 h time point. To
further quantify the effect of the biohybrids on the E. coli
biofilms, crystal violet (CV) staining was employed. The 96-
well plates of 24 h cultured biofilm were washed and incubated
with the proposed biohybrid (MSR-1+CFX-MSMs) or nine
other control groups for 24 or 48 h as seen in Figure 4G. After
incubation with the biohybrid and control groups, biofilms were
stained with CV, and the optical density (OD) at 590 nm
(OD590) was measured to quantify the concentration of E. coli
biofilm. Exposing the biofilms to 0.05 μg mL−1 CFX solutions
resulted in insignificant disruption of the biofilm at both the 24
and 48 h incubation time points, while a higher concentration
of CFX, 0.1 μg mL−1, provided a ∼40% decrease in CV biofilm
absorbance after 24 h that remained constant at 48 h. The
increased concentration is significantly higher than the CFX
concentration needed to reduce planktonic E. coli proliferation,
but the result is expected, as biofilms have been shown to be
less susceptible to antibiotics than free-swimming bacteria.
Biofilms incubated for 24 h with MSR-1, MSMs+MSR-1, CFX-
MSMs, and biohybrids also displayed decreases in biofilm
formation when compared to the unmodified control biofilm,
with biohybrids inducing a 32% decrease in CV absorbance. It
is interesting to note that the MSR-1 bacteria and MSMs
+MSR-1 also produced similar reductions in absorbance
without the assistance of antibiotic after 24 h. We hypothesize
that the locomotion and consumption of resources (nutrients,
oxygen) of large quantities of MSR-1 bacteria have the
capability to disturb the biofilm and prevent static biofilm
development as well, therefore decreasing the CV absorbance.
However, there is no significant change between the 24 and 48
h time points for control groups containing MSR-1, indicating
they would only be useful for temporarily disrupting foreign
biofilm. MSR-1 motility decreases over time and ceases once
the bacteria die and their death is accelerated at physiological
temperatures, leaving MSR-1 inactive 30 to 45 min after
exposure to 37 °C.45 Only the CFX-MSMs group and
biohybrid group (MSR-1+CFX-MSMs) demonstrated a statisti-
cally significant decrease in CV absorbance between the 24 to
48 h time point (25% and 32% decrease, respectively, labeled
with an asterisk in Figure 4G). The biohybrid group also had
the greatest overall decrease in CV absorbance from the
unmodified biofilm control group at 48 h (55%) when
compared to the other controls. In the presence of only
antibiotic solution or MSR-1 bacteria, the E. coli biofilm
disruption plateaus after 24 h, but the antibiotic-loaded
biohybrid swimmer has an increased antibiofilm effect that
continues to disrupt biofilm until 48 h, displaying biohybrids’
therapeutic advantages as an active drug delivery system.
To prove the overall advantage of our biohybrid systems over
current biofilm disruption methodologies, we demonstrated our
swimming biohybrids targeting and delivering their antibiotic
cargo load. Biohybrids powered by MSR-1 were incubated with
E. coli biofilms. Using a permanent magnet, biohybrids were
guided through concentrated E. coli populations to clusters or
islands of dense biofilm (Figure 5). Multiple biofilm regions
were targeted in a single Petri dish using different biohybrids
(Figures 5A and S3), showing the benefits of operating low
numbers of biohybrids to attack multiple microscale targets.
Once the target biofilm clusters were reached, the biohybrids
could be pushed into the biofilm using the force of the MSR-1
Figure 5. Magnetic guidance of biohybrids to E. coli biofilms. (A) Single MSR-1-powered biohybrid magnetically guided to an island of E. coli
biofilm (yellow circle). The biohybrid is pushed into the biofilm and becomes trapped. (B) SEM image of a biohybrid trapped in an E. coli
biofilm. Yellow arrows indicate the location of the MSM. (C) Increased magnification displays EPS and bacteria surrounding the biohybrid.
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propulsion (Video SV5). Although the power of the MSR-1
provides energy to push into the biofilm, once inside, it
becomes trapped within the biofilm matrix, becoming incapable
of further motility (Figure 5B,C). The biofilm EPS is the largest
contributor to the viscoelastic properties of biofilm and has
been shown to deform or rearrange its structure due to external
stress, such as applied pressure or shear forces.1 Penetration of
the biohybrid into the biofilm causes a temporary elastic
deformation, but the high viscosity of the biofilm prevents
further biohybrid swimming. This delivery and capture
mechanism is an efficient method to ensure targeted drug
delivery to the acidic interior biofilm environments. Combining
localized cell adhesion for propulsive force, MSR-1 magnetic
sensing, and MSM drug loading capacity, we have presented a
biohybrid with the potential to disrupt mature E. coli biofilms.
DISCUSSION
Even after decades of research, an in-depth understanding of
biofilm formation and eradication methodologies remains
elusive. There are still many questions regarding the biofilm
EPS composition, bacteria communication within the biofilm
(quorum sensing), and biofilm metabolic pathways to resist
antibiotics.1,7 To engage with such a complex biological system,
a radical alternative to current methods needs to be presented.
The MSR-1-propelled biohybrid demonstrates the feasibility of
using a “hero” nonpathogenic bacteria to deliver antibiotics to
infectious biofilms. The MSR-1 bacteria possesses the ability to
sense and respond to external magnetic fields, allowing the
biohybrid to have targeted antibiotic delivery to motile biofilm
cites and the ability to penetrate the microtubular systems deep
within the biofilm body and EPS, where the drug release is
triggered by biochemical properties of the biofilm. Although
this article has demonstrated a proof-of-concept of application,
there are still many steps forward until such bacteria biohybrids
may be used in vivo.46 Other types of synthetic swimmers, such
as helical nanopropellers20 or micro artificial bacterial flagella,21
do not require bioenergy propulsion, but swim by rotation
using an external rotating magnetic field. These swimmers
could also be considered for the task of antibiotic delivery, as
they offer accurate guidance systems with proven drug delivery
capabilities. However, these systems lack the sophisticated
sensing mechanisms of biological organisms. Helical micro-
swimmer systems require visual observation to be guided
toward their intended target, diminishing their applicability for
drug delivery to concealed locations until there are improved
imaging and resolution techniques. Free swimming bacteria
have also shown to disrupt biofilms by tunneling through the
matrix, allowing toxic chemicals to permeate the biofilm,47 but
there is no navigational control of the tunneling bacteria,
making it difficult to target a precise location. To achieve future
in vivo targeted drug delivery, microswimmers will require
multicomponent guidance systems utilizing external magnetic
control to reach a general location as well as more sensitive
local sensing, such as pH, temperature, or biochemical
guidance, to find specific microenvironments. Bacteria bio-
hyrids incorporate a synthetic component for triggered drug
delivery and a bacterium as a living power source and natural
sensor, giving them an advantage over single-element synthetic
or cellular swimmers. The presented MSR-1-powered biohybrid
moves the microswimmer field closer toward clinical
applications and illustrates that bacteria biohybrids can be
employed for antibiofilm research.
In addition to our biohybrid design properties to target
biofilms, we have also considered the effect of our biohybrid on
nonpathogenic host bacteria. The plethora of varied bacteria in
the human microbiome has only recently been investigated, and
initial research has shown bacteria colonies around the human
body form symbiotic relationships with their hosts. These
relationships have proven essential to maintain good health, as
the natural microflora prevent the overgrowth of opportunistic
and pathogenic microorganisms.48 Antibiotics, including CFX,
have shown to eliminate natural intestinal microbiota, which
results in health problems including alterations in metabo-
lism.49 Although the MIC of CFX required for E. coli has shown
to be <0.06 μg/mL, patients with bacterial infections are given
oral CFX doses of 250 to 750 mg tablets, leading to some
adverse gastrointestinal and nervous system reactions.42,50
Guided manual delivery of antibiotics could also improve the
medical side-effects of nontargeted antibiotics and help
maintain natural host bacteria. As shown in Figure 4G, the
antibiotic-loaded biohybrids have a greater effect at reducing
established biofilm when compared to CFX solutions. By
guiding the biohybrids to defined locations, the potency of the
antibiotic will only be realized at the infection site. Antibiofilm
agents that include protection of natural benign bacteria
improve the efficacy of drug delivery, by localizing bacteria
damage and reducing indirect health complications.
Therapeutic methods could also benefit from the penetration
delivery method of the presented biohybrid. Biofilm survival is
directly linked with its mechanical strength and low metabolic
activity. The biofilm and EPS create a protective shell forming a
physical barrier for the biofilm, and the diminished growth rate
of biofilms limits uptake of local antibiotics. Previous research
with fluoroquinolones has shown the drugs are capable of
penetrating entire biofilms, but even with prolonged exposure
to antibiotics such as CFX, cell death in biofilms is observed
only at the biofilm interface, while the bulk remains viable and
intact.51 The ability for E. coli biofilms to remain viable in
antibiotics is attributed to their efflux pump systems. Efflux
pump genes are highly upregulated during biofilm growth, and
efflux pumps are responsible for waste and toxic substance
removal, including antibiotics, resulting in antibiotic-tolerant
biofilms.52 However, physical disruption and breakage of
biofilms makes biofilm bacteria more susceptible to antibiotics
and therefore easier to treat.9,22 Using magnetic actuation,
magnetotactic bacteria have demonstrated applied mechanical
force on biofilms, resulting in subsequent biofilm damage.53
Combining physical disruption with antibiotic release would
improve the therapeutic effect of antibiofilm agents. The
penetration power of the MSR-1-powered biohybrid pushes
through the outer shell of the biofilm and accesses the low-
metabolic cells within the biofilm core (Figure 5). This drug
delivery method is effective because it utilizes a potent
fluoroquinolone antibiotic and physically damages the biofilm.
It could be envisioned that future therapeutic applications could
use a combination of administered free antibiotic to kill
planktonic bacteria and biohybrids to strike and disrupt
biofilms. The two-pronged approach would be effective at
eradicating robust biofilm cultures that are not affected by
antibiotics alone.
CONCLUSIONS
Biohybrids operate as intelligent micro robotic systems, with a
powerful bioengine and triggered antibiotic delivery. The
presented biohybrids are active drug delivery systems using a
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living bacteria power source with a natural magnetic sensor and
demonstrate the feasibility of an antibiofilm biohybrid. This
report demonstrates the advantages of microswimmer technol-
ogy for the clinically relevant and considerable problem of
biofilm formation and its potential for having greater targeting
and therapeutic capabilities than monocomponent swimmers or
passive drug delivery. Future efforts will focus on increasing the
potency of the systems by exploring other antibiotics, but also
their ability to function in biological non-Newtonian fluids,
such as mucus or saliva. The sensing capabilities of the MSR-1
will also be further probed, by investigating their oxygen
sensitivity to the depleted oxygen zones of the biofilm and
determine if MSR-1 biohybrids could detect and target biofilms
with minimal magnetic navigation. Finally, increasing the
quantity of biohybrids will be investigated to improve the
therapeutic capacity of biohybrid drug delivery systems.
MATERIALS AND METHODS
Fabrication of MSMs. MSMs were synthesized using a cyclopore
PC membrane template, containing 2 μm maximum diameter conical-
shaped micropores (catalog no. 7060-2511; Whatman, Maidstone,
UK). Hexadecyltrimethylammonium bromide (12.5 mg, 99%, Sigma-
Aldrich) and triethanolamine (10 mg, 98%, Sigma-Aldrich) were
dissolved in 4 mL of deionized water in a glass vial containing the
polycarbonate membrane. The mix was heated to 80 °C, and 5 μL of
tetraethyl orthosilicate (TEOS, 99%, Sigma-Aldrich) was added under
stirring. After 30 min at constant temperature, 30 μL of a mixture of
1:2 v/v APTES (Sigma-Aldrich) and TEOS was added. The reaction
was kept at 80 °C for 2 h with stirring. The reaction was removed from
heat, and the solution was kept stirring for 20 min at room
temperature. The membrane was removed, rinsed extensively with
deionized water, and polished on both membrane sides with a moist
cotton swap. The polycarbonate membrane template was dissolved in
1 mL of CH2Cl2 for 15 min, and the released MSMs were collected by
centrifugation at 14 000 rpm for 3 min. MSMs were washed,
centrifuged, and collected 2× in CH2Cl2, 2× in EtOH, and 2× in
deionized H2O. The MSMs were stored in deionized water at room
temperature.
MSR-1 Culture. The cultivation medium from Heyen and
Schüler54 was used to grow MSR-1 in Hungate tubes. Ten milliliters
of a fully grown culture was centrifuged at 5000 rpm for 10 min, and
the resulting pellet was isolated and resuspended at the bottom of a
semisolid medium column (0.1% agar). The motile part of the
population was isolated due to a band formation process in the
column.35 Bacteria suspensions with optical densities between 0.07
and 0.1 (NanoPhotometer Pearl at 565 nm) were used for the guiding
experiments.
Biohybrid Microswimmer Formation. MSR-1 cells were
centrifuged (6000 rpm, 3 min) and resuspended twice in motility
media (0.01 M K3PO4, 67 mM NaCl, 0.1 mM ethylenediaminetetra-
acetic acid, 0.002% v/v Tween-20 (pH adjusted to 7.4)). All
experiments with bacteria were performed in motility media unless
specified. MSMs were added to MSR-1 in motility media and allowed
to incubate at ambient temperature for 15 min before imaging in glass
coverslip bottom Petri dishes (Cellview Cell Culture Dish, Greiner
Bio-One). Videos and images were acquired using bright field
microscopy with an inverted Leica DMI3000B microscope, Leica
DFC3000G camera, and Leica Application Suite v.4.5.0 software. For
magnetic maneuverability and group swimming experiments, a
custom-made microscope35 was utilized to generate magnetic fields
at the sample position during microscopy. Briefly, a triaxial Helmholtz
coil setup (C-SpinCoil-XYZ, Micro Magnetics Inc.) was used to
generate a homogeneous magnetic field inside the region of interest
directly above the microscope objective. The sample was illuminated
with a red LED, and the images were captured with a CMOS camera
at 10 Hz (2560 × 2160 pixels; NeosCMOS, Andor Technology). For
“U-turn” analysis, magnetic fields were generated with four
orthogonally oriented iron-core electromagnets. The coils were built
onto another custom-made microscope stage to surround a 35 mm
Petri dish and placed onto an inverted Zeiss (Carl Zeiss, Inc.,
Oberkochen, Germany) Axio Observer A1 microscope with a 20×
(NA = 0.5) objective lens. The input current for the coils was
controlled by motor drivers and an Arduino microcontroller board,
and the ∼6 mT magnetic field strength was calibrated using a Lake
Shore Cryotronics (Darmstatdt, Germany) model 460-3-channel
gaussmeter. For acquiring swimming velocities, MSR-1 and biohyrids
were recorded with a Zeiss Axiocam 503 CCD camera. Tracking of
MSR-1 and or biohybrids was performed with ImageJ Fiji 1.49s
MTrackJ manual tracking software or an in-house-developed script in
Python with the OpenCV library using recorded videos. Thresholding
criteria were used to distinguish bacteria and tubes from the
background with their positions taken as the center of mass of the
contour. Bayesian decision making determined the trajectory of the
motors over time.
SEM and TEM Imaging of Bacteria and Biohybrids. Bacteria
and tubes were imaged with a Zeiss Ultra 55 Gemini scanning electron
microscope using an accelerating voltage of 5 keV and an in-lens
detector. To prepare samples for SEM, biohybrids suspended in
motility media were allowed to sediment on clean, plasma-etched (1
min argon plasma, Diener Electronic Atto Plasma Cleaner) silicon
wafer chips (5 × 6 mm) for 1 h at ambient temperature. For biofilm, E.
coli were allowed to culture on wafers at 30 °C for 72 h and then
washed with phosphate-buffered saline (PBS). Wafers were incubated
in 2.5% glutaraldehyde in PBS for 45 min at 4 °C and rinsed with PBS,
then water. Bacteria were dehydrated in a series of increasing aqueous
ethanol concentrations (30%, 50%, 70%, 90%, and 100%) for 5 min in
each solution and 10 min in pure ethanol. Bacteria were further
dehydrated and preserved using a series of hexamethyldisilazane
(HMDS, Sigma-Aldrich) solutions: 2:1 ethanol/HMDS (15 min), 1:2
ethanol/HMDS (15 min), pure HMDS (15 min). Wafers and bacteria
were air-dried for 2 h followed by sputtering deposition of 3 nm gold
using a Bal-tec MED 020 coating system (Leica). Low-magnification,
bright field, TEM images of bacteria and MSMs were acquired with a
Zeiss EM 912 Omega at 120 kV.
Loading MSMs with CFX (CFX-MSMs). Five mg/mL cipro-
floxacin (CFX, Sigma-Aldrich) was dissolved in 0.1 M aqueous HCl.
Then 60 μL of the concentrated CFX solution was added to 540 μL of
MSMs in water. MSMs with CFX were shaken overnight in a pulse
vortex mixer (1500 speed) at ambient temperature. MSMS were
collected by centrifugation at 20 000 rpm for 6 min and resuspended
twice in motility media. CFX-MSMs were used immediately for CFX
release measurements or biohybrid formation.
CFX Release from CFX-MSMs. Freshly made CFX-MSMs
suspended in 1 mL of motility media at pH 5.8 or 7.4 in an
Eppendorf tube were centrifuged at 20 000 rpm for 6 min. A 400 μL
amount of supernatant was collected from the tube, without disturbing
the CFX-MSMs pellet, and was divided into two 200 μL aliquots in a
black, flat-bottom, chimney 96-well plate (Greiner Bio-One). Well
plates also contained calibration samples of CFX in motility media (0,
0.05, 0.1, 0.3, 0.5, 0.8, and 1.0 μg/mL) at pH 5.8 or 7.4. Samples’
fluorescence intensity was measured with a Tecan Infinite M200
multifunctional reader and Tecan i-control 1.10 software. The
excitation wavelength and emission wavelength were set to 280 and
425 nm, respectively. After analysis, the supernatant was returned to
the CFX-MSMs Eppendorf tube and gently shaken to break up the
microtube pellet. These measurements were repeated for the given
time points: 0, 0.5, 1, 3, 4, 6, 7, and 24 h. Release experiments were
repeated in triplicate. The calibration curves (Figure S4) in each
measurement were used to calculate the concentration of supernatant
in the sample solution at each pH.
E. coli Biofilm Formation. E. coli MG1655 cultured on LB agar
plates (Sigma-Aldrich) were transferred to 5 mL of LB broth (Sigma-
Aldrich) and allowed to divide overnight at 30 °C and 150 rpm. A 50
μL amount of concentrated MG1655 solution was diluted in 5 mL of
fresh LB broth. A diluted E. coli solution was plated in sterile nontissue
culture treated 96-well plates (Eppendorf) or Petri dishes with glass
bottoms and allowed to culture for 24 or 48 h at 30 °C for biofilm
formation. LB broth was removed and replaced with motility media.
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For inhibition studies of biofilm formation with CFX, diluted E. coli
solutions in LB broth were plated in a 96-well plate with various
concentrations of CFX (0−0.3 μg/mL), with 200 μL per well. The
optical density of each well was measured at 600 nm (OD600) with a
BioTek Gen5 Synergy 2 plate reader every 20 min for 15 h at 30 °C
with gentle shaking.
Visualization of Biofilms. Confocal imaging was performed with
a Nikon Eclipse Ti confocal microscope equipped with an Andor
EMCCD camera (iXon Ultra 888, 1024 × 1024 sensor format of 13
μm × 13 μm pixel size, Belfast, UK) and a Yokogawa CSU-W1
spinning disk. A CFI Plan Apo VC 20× (NA = 0.75) and a Plan Apo
VC 60× oil (NA = 1.4) objective lens were used for all 3D confocal
images. Twenty-four hour matured E. coli biofilms cultured on glass
bottom Petri dishes were washed once with motility media. For
imaging live and dead cells within the biofilm, motility media was
removed and the biofilms were incubated with 2 μL/mL of propidium
iodide and 2 μL/mL of STYO 9 (Life Technologies) in motility media
for 15 min. Dye solution was removed, and the biofilm was stained
with 1 μM LysoSensor Blue DND-167 (Life Technologies) for 1 h at
37 °C, followed by gentle washing with fresh motility media. pH
distribution within the biofilm architecture was reconstructed using
Nikon NIS AR software (v.4.60). For analysis of biofilms with
microtubes, biofilms were incubated with MSMs or CFX-MSMs.
Unmodified biofilms were used as a control group. Live/dead labeling
and imaging was performed as described previously. A set of biofilms
were stained after the initial incubation with MSMs or CFX-MSMs (t
= 0 h), and separate biofilm sets were stained 24 h after incubation
with the microtubes for comparison. The staining solution was
removed, and the biofilms were rinsed once with motility media. 3D
confocal imaging of the biofilms was used to observe each
experimental group. To visualize the release of CFX from CFX-
MSMs, CFX-MSMs were incubated with a 24 h matured E. coli
biofilm. Time-lapsed 3D confocal images of CFX fluorescence were
taken over 24 h. Since only CFX fluorescence was imaged, biofilm
absorbing the CFX from the CFX-MSMs could be observed.
CV Biofilm Assay. Biofilm CV analysis protocol was adapted from
Merrit et al.55 Sterile nontissue culture treated 96-well plates
(Eppendorf) had 100 μL aliquots of bacteria solution placed in each
well or LB broth as a control. Biofilm was cultured for 24 h at 30 °C in
a static environment. LB broth was removed, and each well of the
biofilm was washed with 2× with motility media. The motility media
was removed, and wells were incubated with 100 μL of biohybrids or
experimental control groups in motility media (0.05 μg/mL CFX, 0.1
μg/mL CFX, MSR-1, MSMs, MSR-1+MSMs, CFX-MSMs, and CFX-
MSMs+MSR-1). Unmodified biofilm wells, blank wells, and wells with
LB broth were used as controls. Each experimental parameter had five
wells. The OD600 of MSR-1 was kept at ∼0.04 for all experiments. The
OD600 was obtained from 200 μL of motility media with MSR-1 in a
96-well plate at ambient temperature using bacteria-free media for a
control. The density of MSMs and CFX-MSMs for all experimental
parameters was kept at ∼20 000 microtubes per well. E. coli biofilms
were incubated with control groups and biohybrids for 24 h at 25 °C
in a static environment. Media and controls were removed, and wells
were washed once with fresh motility media. A 125 μL amount of 0.1%
w/v aqueous CV (Sigma-Aldrich) was put in each well and stained the
biofilms for 10 min. Stain was removed, and wells were washed 3×
with 150 μL of deionized water. Water was removed, and wells were
allowed to air-dry for 15 min followed by incubation with 200 μL of
80% v/v ethanol in water for 15 min to solubilize the biofilm. CV
solutions were pipetted into a new 96-well plate and had their OD590
measured with the BioTek plate reader. The CV biofilm assay was
repeated in triplicate, and statistical significance of the data was
evaluated using one-way analysis of variance (ANOVA) followed by
post hoc Bonferroni tests to compare individual means using OriginPro
9.10 software. The level of statistically significant data had P-values of
0.01 or less when compared to the umodified biofilm group.
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